Epitope specific T-cell responses against influenza A in a healthy population.
Miloje SavicJennifer L DembinskiYohan KimGro TunheimRebecca J CoxFredrik OftungBjoern PetersSiri MjaalandPublished in: Immunology (2015)
Pre-existing human CD4(+) and CD8(+) T-cell-mediated immunity may be a useful correlate of protection against severe influenza disease. Identification and evaluation of common epitopes recognized by T cells with broad cross-reactivity is therefore important to guide universal influenza vaccine development, and to monitor immunological preparedness against pandemics. We have retrieved an optimal combination of MHC class I and class II restricted epitopes from the Immune Epitope Database (www.iedb.org), by defining a fitness score function depending on prevalence, sequence conservancy and HLA super-type coverage. Optimized libraries of CD4(+) and CD8(+) T-cell epitopes were selected from influenza antigens commonly present in seasonal and pandemic influenza strains from 1934 to 2009. These epitope pools were used to characterize human T-cell responses in healthy donors using interferon-γ ELISPOT assays. Upon stimulation, significant CD4(+) and CD8(+) T-cell responses were induced, primarily recognizing epitopes from the conserved viral core proteins. Furthermore, the CD4(+) and CD8(+) T cells were phenotypically characterized regarding functionality, cytotoxic potential and memory phenotype using flow cytometry. Optimized sets of T-cell peptide epitopes may be a useful tool to monitor the efficacy of clinical trials, the immune status of a population to predict immunological preparedness against pandemics, as well as being candidates for universal influenza vaccines.
Keyphrases
- endothelial cells
- flow cytometry
- clinical trial
- public health
- sars cov
- nk cells
- high glucose
- escherichia coli
- monoclonal antibody
- risk factors
- dendritic cells
- induced pluripotent stem cells
- body composition
- healthcare
- transcription factor
- randomized controlled trial
- high throughput
- working memory
- pluripotent stem cells
- emergency department
- risk assessment
- stress induced
- open label
- study protocol